期刊文献+

组织金属蛋白酶抑制剂-2与大肠癌浸润转移的关系 被引量:5

The relationship between MMP-2 and infiltration, metastasis of color-ectal cancer
暂未订购
导出
摘要 目的 探讨组织金属蛋白酶抑制剂-2(TIMP-2)表达与大肠癌浸润转移的关系。方法 采用S-P免疫组织化学染色技术,检测30例大肠腺瘤,60例大肠癌组织TIMP-2的表达情况。结果 TIMP-2的表达在大肠腺瘤和大肠癌组织中没有显著性差异(P>0.05);但其表达与大肠癌的Dukes分期、淋巴结转移、远隔脏器转移及生存期均有关(P<0.05)。结论TIMP-2的检测可以成为临床判断大肠癌的恶性程度、转移及预后的重要参考指标。 Objective To investigate the role of the expressionof Tissue inhibitor of metalloproteinase-2 (TIMP-2) in invasion andme-tastasis of colorectal cancer( CRC) . Methods The TIMP-2 expression was studied immuneohistochemistrically in 30 specimens of color-ectaladenoma and 60 specimens of CRC. Results No apparent correlation was observed between the expression of TIMP-2 and colorectal adenoma and CRC ( P > 0.05), Significant relationship was observed between low TIMP-2 expression and Dukes stage, metastasis of lymph node anddistant organs and poor prognosis. Conclusion The detection of expression about TIMP-2 may be helpful to judge the malignant behavior, metastasis andprognosis with colorectal carcinoma.
出处 《实用肿瘤学杂志》 CAS 2003年第1期1-3,共3页 Practical Oncology Journal
关键词 组织金属蛋白酶抑制剂-2 大肠癌 肿瘤浸润 肿瘤转移 Colorectal cancer Tissue inhibitor of metalloproteinase-2 Invasion Metastasis
  • 相关文献

参考文献8

  • 1Gumbiner B, Stevenson B, Grimaldi A. The role of the cell adhesion molrcule uvomorulin in the formation and maintenance of the epithelial junctional complex [J]. Cell Biol, 1998; 107:1575~1587.
  • 2Graeme I. Murray. Matrix metaloproteinases: a multfunctional group of molecules [J]. J Pathol, 2001;195:135~137.
  • 3Liotta LA, Tryggyason K, Garbisa S, et al. Metastatic potiential correlates with enzymatic degradation of basement membrane collagen[J].Nature (Lond), 1980;284:67.
  • 4Ring P, Johansson K, Hoyhtya M, Davies B. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer-a predictor of tumour stage[J]. British journal of cancer. 1997; 76(6):805~11.
  • 5Lotz M, Guerne PA. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinase- 1(TIMP-1)/enythoid potentiating activity[J].Biol Chem, 1991;266:11563.
  • 6Joo YE, Seo KS, Kim J. Role of tissue inhibitors of metaloproteinases (TIMPs) in colorectal carcinoma [J]. Journal of Korean medical science. 1999; 14(4):417~23.
  • 7Ikuchi R, Noguchi T. Immunohistochemical detection of membranetype1-matrix metalloproteinase in colorectal carcinoma [J]. British joumal of cancer. 2000; 83(2):215~8.
  • 8Kanayima HO,Yokota K, Kurokawa Y. Prognostic values of matrix metaloproteinase-2 and tissue inhibitor of metaloproteinase-2 expression in bladder cancer[J]. Cancer. 1998;82(7):1359~66.

同被引文献90

  • 1王军,罗兵.基质金属蛋白酶及其抑制物与肿瘤相关性研究进展[J].实用医药杂志,2006,23(2):218-221. 被引量:12
  • 2Steward WP. Marimastat ( BB2516 ): current status of development[J]. Cancer Chemother Pharmacol, 1999, 43: 56-60.
  • 3Kleiner D , Stetler-Stevenson W. Matrix metalloproteinases and metastasis[J]. Cancer Chemother Phamacol, 1999, (80):862.
  • 4Ohashi K, Nemoto T, Nakamura K, et aL Increased expression of matrix metalloproteinase7 and 9 and membrane typel-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer,2000,88(10):2201-2209.
  • 5Morgan AR,Zhang B,Tapper W,et al. Haplotypic analysis of the MMP9 gene in relation to coronary artery disease. J Mol Med,2003,81(5):321-326.
  • 6Joos L, He JQ,Megan B,et al. The role of matrix metaloproteinase polymorphisrns in the rate of decline in lung function. Hum Mol Genet,2002,11(5):569-576.
  • 7Kerkela E,Ala-Aho R, Jeskanen L,et al. Expression of human macrophage metalloelastase (MMP12) by tumor colls in skin cancer. J Invest Dermatol,2000,114(6):1113-1119.
  • 8Ding Y, Shimada Y, Gorrin-Rivas MJ, et al. Clinicopathological significanco of human macrophage metalloelsstase expression in esophageal squamous cell carcinoma. Oncology,2002,63 (4):378-384.
  • 9Szyllo K,Smolarz B,Romanowicz-Makowska H,et al. The promoter polymorphism of the matrix metalloproteinase3 (MMP3)gene in women with ovarian cancer. Exp Clin Cancer Res, 2002,21 (3):357-361.
  • 10Liu PY,Chen JH,Li YH,et al. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction. Thromb Haemost,2003,90(1):132-139.

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部